Try a new search

Format these results:

Searched for:

in-biosketch:true

person:cerfor01

Total Results:

401


The benefits of continuous and digital air leak assessment after elective pulmonary resection: a prospective study

Cerfolio, Robert J; Bryant, Ayesha S
BACKGROUND: Air leaks remain the most common pulmonary complication after elective pulmonary resection, yet their assessment, unlike other clinical bedside indicators, remains analogue and not digital. METHODS: This prospective randomized study compared a digital air leak system with the current analogue air leak system in 100 patients that underwent elective pulmonary resection. RESULTS: The digital and analogue patient groups each had 50 patients. Pulmonary function, types of pulmonary resection, number of chest tubes, and pathology were not statistically different between the groups. The digital system confirmed the air leak status in 5 patients that were equivocal on the analogue system. The ability to assess the air leak status continuously afforded quicker chest tube removal in the digital group (mean, 3.1 vs 3.9 days, p = 0.034) and reduced hospital stay (mean, 3.3 vs 4.0 days, p = 0.055). Three patients were discharged home with the device, without complications. CONCLUSIONS: The digital and continuous measurement of air leaks instead of the currently used static analogue systems reduces hospital length of stay by more accurately and reproducibly measuring air leaks. This leads to quicker chest tube management decisions because the average size of an air leak during the last several hours can be determined. Intrapleural pressure curves may also help predict the optimal chest tube setting for each patient's air leak and eliminate the need for chest roentgenograms. Further studies on the pleural pressure curves and this device are needed.
PMID: 18640304
ISSN: 1552-6259
CID: 2539132

Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer

Cerfolio, Robert J; Bryant, Ayesha S
BACKGROUND: The objective of this study was to determine the survival of patients who have completely resected, nonsmall-cell, stage IIIA, lung cancer from unsuspected (nonimaged) N2 disease who received adjuvant chemotherapy. METHODS: This is a retrospective cohort study using a prospective database. All patients underwent positron emission tomography scan and computed tomography scan with contrast, R0 resection with complete thoracic lymphadenectomy, and had unsuspected, pathologic N2 NSCLC. RESULTS: Between June 1998 and December 2007, there were 148 patients (89 men). The most common pulmonary resection was right upper lobectomy in 67 patients (48%), and the most common lymph node station for unsuspected N2 diseased was 4R. One hundred and thirty-seven patients (93%) received adjuvant chemotherapy and 13% received postoperative radiation as well. The overall 2- and 5-year survivals were 58% and 35%, respectively. The 5-year survival for the 98 patients with single lymph node disease compared with patients with multiple nodal involvement was 40% versus 25%, respectively (p = 0.028). The number of lymph nodes involved (p = 0.032) was an independent predictors of survival on multivariate analysis. Median follow-up was 54 months. CONCLUSIONS: The 5-year survival of patients with unsuspected N2 disease who undergo complete resection, followed by adjuvant therapy, is 35%. Patients with single station N2 disease fare better. The role for mediastinoscopy, endoscopic esophageal ultrasound with fine-needle aspirate, or endobronchial ultrasound in patients who are negative by positron emission tomography and computed tomography is unknown, since the benefit of neoadjuvant therapy in these patients is also unproven. A randomized study is needed.
PMID: 18640297
ISSN: 1552-6259
CID: 2539142

Angiomyolipoma of the anterior mediastinum [Case Report]

Knight, Carrie S; Cerfolio, Robert J; Winokur, Thomas S
Angiomyolipoma is a benign tumor composed of varying proportions of smooth muscle cells, blood vessels, and adipose tissue that most commonly occurs in the kidney. Sporadic lesions and lesions arising in the setting of the tuberous sclerosis complex have been reported in extrarenal sites. We present the case of an incidentally discovered angiomyolipoma in the anterior mediastinum. Thymoma was suspected clinically, and the lesion was composed mainly of spindled-to-epithelioid cells arranged in a histologic pattern reminiscent of hemangiopericytoma, a pattern that has been described in thymoma. Immunohistochemical stains revealed positivity for smooth muscle actin and HMB-45, revealing the expression of smooth muscle and melanocytic markers characteristic of angiomyolipoma and other lesions in the PEComa family.
PMID: 18620999
ISSN: 1532-8198
CID: 2539152

Rigid bronchoscopy and surgical resection for broncholithiasis and calcified mediastinal lymph nodes

Cerfolio, Robert J; Bryant, Ayesha S; Maniscalco, Lee
BACKGROUND: Patients with calcified mediastinal lymph nodes who have hemoptysis or lithoptysis represent a challenging therapeutic dilemma. METHODS: We performed a retrospective review of a prospective clinic and operative database between January 1998 and December 2006. All patients had calcified mediastinal lymph nodes, symptoms or complications from these nodes, or both. RESULTS: There were 50 patients (23 men). Thirty-eight (76%) were symptomatic, which included hemoptysis in 11, persistent cough in 8, and recurrent pneumonia in 5, and all underwent rigid bronchoscopy. Thirty-four (89%) of the 38 symptomatic patients had stones eroding into the airway (broncholiths), and 2 had an airway esophageal fistula. The most common location of the broncholith was in the bronchus intermedius (n = 19). Endoscopic removal of the broncholith was performed in 29 patients and was successful in all. Elective thoracotomy with lymph node curettage, removal, or both was performed in 5 patients. These 5 patients had no significant morbidity and no operative mortality. Patients remained symptom free (median follow-up, 2.3 years; range, 8-42 months). Twelve asymptomatic patients with calcified lymph nodes were followed with serial computed tomographic scans and remain asymptomatic (median follow-up, 3.1 years). CONCLUSIONS: Broncholiths that are not fixed to the airway can be safely removed with rigid and flexible bronchoscopic equipment. Thoracotomy with broncholithectomy is also safe and effective and is reserved for symptomatic lesions that cannot be removed bronchoscopically or for lesions that cause airway esophageal fistulas. Calcified nodes in asymptomatic patients are not an indication for intervention.
PMID: 18603074
ISSN: 1097-685x
CID: 2539162

Survival among patients with platinum resistant, locally advanced non-small cell cancer (stage II and III) treated with platinum-based systemic therapy [Meeting Abstract]

D'Amato, TA; Pettiford, BL; Schuchert, MJ; McKenna, RJ; Cerfolio, RJ; Ricketts, WA; Santos, RS; Luketich, JD; Landreneau, RJ
ISI:000252887900087
ISSN: 1068-9265
CID: 2540542

Does the amount of fluid really matter for drain removal after lung resection? Reply [Letter]

Cerfolio, Robert James
ISI:000258535300050
ISSN: 0022-5223
CID: 2540562

Prospective algorithm to remove chest tubes after pulmonary resection with high output - is it valid everywhere? - Reply [Letter]

Cerfolio, Robert J
ISI:000258535300052
ISSN: 0022-5223
CID: 2540572

Pneumonectomy

Chapter by: Cerfolio, Robert
in: Mastery of cardiothoracic surgery by Kaiser, Larry R; Kron, Irving L; Spray, Thomas L (Eds)
Philadelphia : Lippincott, Williams & Wilkins, 2007
pp. ?-?
ISBN: 9780781752091
CID: 4070072

Targeting lung cancer using an infectivity enhanced CXCR4-CRAd

Zhu, Zeng B; Rivera, Angel A; Makhija, Sharmila K; Lu, Baogen; Wang, Minghui; Izumi, Miiru; Cerfolio, Robert J; Stoff-Khalili, Mariam A; Zhou, Fen; Takayama, Koichi; Siegal, Gene P; Curiel, David T
Conventional treatments are not adequate for the majority of lung cancer patients. Conditionally replicating adenoviruses (CRAds) represent a promising new modality for the treatment of neoplastic diseases, including non-small cell lung cancer. Specifically, following cellular infection, the virus replicates selectively in the infected tumor cells and kills the cells by cytolysis. Next, the progeny virions infect a new population of surrounding target cells, replicate again and eradicate the infected tumor cells while leaving normal cells unaffected. However, to date, there have been two main limitations to successful clinical application of these CRAd agents; i.e. poor infectivity and poor tumor specificity. Here we report the construction of a CRAd agent, CRAd-CXCR4.RGD, in which the adenovirus E1 gene is driven by a tumor-specific CXCR4 promoter and the viral infectivity is enhanced by a capsid modification, RGD4C. This agent CRAd-CXCR4.RGD, as expected, improved both of the viral infectivity and tumor specificity as evaluated in an established lung tumor cell line and in primary tumor tissue from multiple patients. As an added benefit, the activity of the CXCR4 promoter was low in human liver as compared to three other promoters regularly used for targeting tumors. In addition, this agent has the potential of targeting multiple other tumor cell types. From these data, the CRAd-CXCR4.RGD appears to be a promising novel CRAd agent for lung cancer targeting with low host toxicity.
PMCID:1853277
PMID: 17113184
ISSN: 0169-5002
CID: 2539432

The role of integrated positron emission tomography-computerized tomography in evaluating and staging patients with non-small cell lung cancer

Cerfolio, Robert James; Bryant, Ayesha S
The stage of non-small cell lung cancer (NSCLC) determines that the treatment strategy and proper staging lead to improved survival. Integrated positron emission tomography/computerized tomography (CT) scan provides more accurate staging and better targets for biopsy than traditional methods such as CT scans of the chest and upper abdomen, bone scans, and magnetic resonance imaging scans. Integrated positron emission tomography/CT is the best initial test for an indeterminate pulmonary nodule that is 8 mm or greater; for the noninvasive staging of patients with NSCLC, it is the only test that produces a quantitative assessment of an NSCLC's virulence or biologic aggressiveness in a particular patient and is the best tool for restaging patients after radiation and and/or chemotherapy. Finally, its use as a tool for postoperative surveillance is under study.
PMID: 17983944
ISSN: 1043-0679
CID: 2539272